Plain-English translation of NCT05752812 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers have developed a prediction score called the HELPP score that uses routine blood tests and basic health information to estimate how well patients with pancreatic cancer might do after treatment. This study is testing whether this scoring system works accurately in real clinical practice across multiple hospitals. The goal is to see if the score can help doctors predict survival and recurrence patterns using only information doctors already have.
Pancreatic cancer is difficult to predict because tumors vary greatly from person to person, and some patients may have undetectable cancer spread. If this scoring system works, it could help doctors choose better treatments for each patient, improve how patients are selected for clinical trials, and provide new insights into why pancreatic cancers behave differently.
You likely qualify if…
You likely don't qualify if…
As a participant, you would have routine blood tests and imaging done before your cancer treatment, which doctors would already be ordering anyway. Researchers would collect your basic health information, pathology results, and treatment outcomes over at least 24 months of follow-up care. You would not need to make extra visits or take additional medications — the study simply tracks information your medical team already gathers.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Austria
Sponsor
Medical University of Vienna
Enrollment target
~1,500 participants
Started
March 2023
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 99 Years
Last updated on clinicaltrials.gov in October 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Carl Leonhardt, MD MBA
Medical University Vienna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.